# AN2 THERAPEUTICS INC (ANTX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ANTX/

- Reporting holders: 1
- Reported value: $1.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $1.0K | 191 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 1 | $1.0K |
| Q2 2026 | 67 | $128.1M |
| Q1 2026 | 52 | $77.2M |
| Q4 2025 | 38 | $9.9M |
| Q3 2025 | 36 | $12.3M |
| Q2 2025 | 37 | $8.8M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.9M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $423.1M |